Genetic diversity, inbreeding and cancer by Ujvari, Beata et al.
HAL Id: hal-01783670
https://hal.archives-ouvertes.fr/hal-01783670
Submitted on 18 May 2018
HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.
L’archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d’enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.
Genetic diversity, inbreeding and cancer
Beata Ujvari, Marcel Klaassen, Nynke Raven, Tracey Russell, Marion
Vittecoq, Rodrigo Hamede, Frédéric Thomas, Thomas Madsen
To cite this version:
Beata Ujvari, Marcel Klaassen, Nynke Raven, Tracey Russell, Marion Vittecoq, et al.. Genetic diver-
sity, inbreeding and cancer. Proceedings of the Royal Society B: Biological Sciences, Royal Society,
The, 2018, ￿10.1098/rspb.2017.2589￿. ￿hal-01783670￿
 on March 21, 2018http://rspb.royalsocietypublishing.org/Downloaded from rspb.royalsocietypublishing.orgReview
Cite this article: Ujvari B, Klaassen M, Raven
N, Russell T, Vittecoq M, Hamede R, Thomas F,
Madsen T. 2018 Genetic diversity, inbreeding
and cancer. Proc. R. Soc. B 285: 20172589.
http://dx.doi.org/10.1098/rspb.2017.2589Received: 16 November 2017
Accepted: 28 February 2018Subject Category:
Evolution
Subject Areas:
evolution, genetics, ecology
Keywords:
genetic diversity, inbreeding, oncogenic
mutations, oncogenic pathogens, human and
wildlife cancerAuthor for correspondence:
Thomas Madsen
e-mail: madsen@uow.edu.au†These authors contributed equally to the
work.
Electronic supplementary material is available
online at https://dx.doi.org/10.6084/m9.
figshare.c.4024456.& 2018 The Author(s) Published by the Royal Society. All rights reserved.Genetic diversity, inbreeding and cancer
Beata Ujvari1,2,†, Marcel Klaassen1, Nynke Raven1, Tracey Russell3,
Marion Vittecoq4, Rodrigo Hamede1,2, Frédéric Thomas5
and Thomas Madsen1,6,†
1Centre for Integrative Ecology, School of Life and Environmental Sciences, Deakin University, Waurn Ponds,
Victoria 3216, Australia
2School of Biological Sciences, University of Tasmania, Private Bag 55, Hobart, Tasmania 7001, Australia
3School of Life and Environmental Sciences, University of Sydney, Sydney, New South Wales 2006, Australia
4Institut de Recherche de la Tour du Valat, le Sambuc, 13200 Arles, France
5CREEC/MIVEGEC, UMR IRD/CNRS/UM 5290, 911 Avenue Agropolis, BP 64501, 34394 Montpellier Cedex 5, France
6School of Biological Sciences, University of Wollongong, Wollongong, New South Wales 2522, Australia
BU, 0000-0003-2391-2988; TM, 0000-0002-0998-8372
Genetic diversity is essential for adaptive capacities, providing organisms
with the potential of successfully responding to intrinsic and extrinsic chal-
lenges. Although a clear reciprocal link between genetic diversity and
resistance to parasites and pathogens has been established across taxa, the
impact of loss of genetic diversity by inbreeding on the emergence and
progression of non-communicable diseases, such as cancer, has been over-
looked. Here we provide an overview of such associations and show that
low genetic diversity and inbreeding associate with an increased risk of
cancer in both humans and animals. Cancer being a multifaceted disease,
loss of genetic diversity can directly (via accumulation of oncogenic homo-
zygous mutations) and indirectly (via increased susceptibility to oncogenic
pathogens) impact abnormal cell emergence and escape of immune surveil-
lance. The observed link between reduced genetic diversity and cancer in
wildlife may further imperil the long-term survival of numerous endangered
species, highlighting the need to consider the impact of cancer in conserva-
tion biology. Finally, the somewhat incongruent data originating from
human studies suggest that the association between genetic diversity and
cancer development is multifactorial and may be tumour specific. Further
studies are therefore crucial in order to elucidate the underpinnings of the
interactions between genetic diversity, inbreeding and cancer.1. Introduction
Genetic diversity provides populations with the ability to respond to
challenges, such as parasites/pathogens, predators and environmental pertur-
bations (electronic supplementary material, table S1). Attenuation of genetic
diversity has been linked to increased risk of inbreeding depression, resulting
in decreased growth rate, fertility, fecundity and offspring viability [1–9], as
well as in increased vulnerability to pathogens [10–12]. Loss of genetic diver-
sity therefore has a negative impact on organismal fitness, and limits a
population’s ability to respond to threats in both the long and short term (for
review see [13]). Akin to parasites, malignant transformations that emerge
due to environmental challenges, infections and/or host genotype either in iso-
lation or via the interaction between genotype and environment exploit the host
for energy and resources, and thereby impair host fitness and pose as a signifi-
cant selective force [14–16]. Indeed, recent studies have proposed that
malignant cells should be regarded as a developing species that behave in a
manner akin to parasites [17]. Consequently, multicellular hosts that have the
genetic toolkit to recognize and control cancer causing infections and malignant
cell proliferation will have a significant fitness advantage over those that lack
such mechanisms. Although a clear reciprocal link between genetic diversity
and vulnerability to parasites and pathogens has been widely acknowledged
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looked how reduced genetic diversity and inbreeding may
influence the appearance and progression of non-communic-
able diseases, such as cancer. Here we discuss how genetic
diversity and inbreeding may contribute to increased risk of
cancer development and progression in humans and animals.ypublishing.org
Proc.R.Soc.B
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Cancer, the uncontrolled division of neoplastic cells, is a ubi-
quitous disease of metazoans [18] and has been proposed to
have appeared with one of the major transitions of life (i.e.
the transition from unicellularity to multicellularity) [19].
Fossilized bones, mummified tissues and phylogenetic
analyses of oncogenic pathogens show that malignant
transformations have been afflicting human and animal
populations for eons (reviewed in [20]).
Although cancer is a multifactorial disease, only a small
proportion of human cancers (less than 10%) originates from
inherited mutations [21]. The majority of familial human can-
cers have been proposed to root from high-penetrance genetic
variants or polymorphisms [22]. For example, specific
inherited mutations in BRCA1 and BRCA2 genes account
for 5–10% of all breast cancers [23], and inherited mutations
of the APC gene is associated with 1–2% of all colon cancers
[24]. Similarly, cancer predisposition by rare, high-penetrance
alleles (e.g. mutations in c-KIT, P53, BRCA1/2) have also been
observed in animal malignancies [25–27].
The majority of human cancer cases can be attributed to
advanced age [28] and/or to acquired mutations due to
environmental factors (including pathogen infections, exposure
to pollution or sunlight, as well as lifestyle, economic and
behavioural factors) [20,21] (see also https://www.cancer.gov/
about-cancer/causes-prevention/risk). Human lifestyle parti-
cularly is one of the underlying factors of cancer development
as almost 25–30% of all cancer-related human deaths are due to
tobacco and 30–35% are linked to diet (reviewed in [21]).
Several of the factors resulting in increased cancer preva-
lence in humans such as smoking, alcohol and diet are highly
unlikely to cause cancer in animals (but see [29,30]), whereas
stress [31–33], infections (reviewed in [34]) and exposure to
environmental carcinogens have been found to increase
cancer prevalence in other vertebrates, such as the brown
bullhead (Ameiurus nebulosus) [35], California sea lion (Zalophus
californianus) [36] and beluga whales (Delphinapterus leucas) [37].
Infections are the direct or indirect underlying factors of a
substantial proportion of both human and animal cancers [38].
Pathogens (particularly intracellular parasites) that alter cellu-
lar regulatory mechanisms (e.g. apoptosis, cell-cycle arrest),
increase cell proliferation rates and break down cellular con-
trols that would prevent oncogenesis can directly contribute
to neoplasm formation. Inflammatory responses initiated by
pathogen infections may also increase mutation rates and
alter proliferation signals, and hence indirectly initiate
malignant transformations (reviewed in [38,39]).
Viruses are the major agents of infection-initiated
vertebrate cancers, and seven viruses have been now
acknowledged as infectious causes of human cancers (e.g.
gamma herpes virus indicated in nasopharyngeal, gastric
cancers; Hodgkin’s lymphoma, Burkitt’s lymphoma) [38].
Similarly, many oncogenic viruses have been associated
with malignancies in domestic and wild animals, such asthe oncogenic papillomavirus in rabbits [40] and a gamma
herpesvirus associated with urogenital carcinoma in
California sea lions (Zalophus californianus) [41].
Apart from viruses, the most frequent sources of infection-
induced cancers are protozoans (e.g. Plasmodium falciparum)
[42], bacteria (e.g. Helicobacter pylori) [43,44] and trematodes
(e.g. Schistosoma haematobium) [43,45] have all been shown to
directly or indirectly cause malignancies. Although rare,
contagious cancers without underlying infectious aetiologies
do occur in the wild, and eight naturally occurring transmis-
sible cancers—one lineage in dogs [46], two lineages in
Tasmanian devils (Sarcophilus harrisii) [47,48] and five lineages
in bivalves [49]—have so far been recorded.3. Genetic diversity, inbreeding and cancer in
humans
Several reports provide evidence that low genetic diversity
and inbreeding may increase cancer risk and that cancer
may have a recessive basis in humans [50–52]. For example,
thyroid cancer has been found to be associated with signifi-
cantly higher levels of inbreeding as well as a higher
number and longer runs of homozygosity (ROH) [53], and
acute leukaemia have been found to be linked to low levels
of genetic diversity and inbreeding [54]. Moreover, extended
germline homozygosity has been shown to result in an
increased risk of lung cancer [55] and homozygosity of the
MTHFR gene has been found to be associated with an
increased risk of breast cancer [56].
Genome-wide association studies have also found a sig-
nificant association between recessive alleles/inbreeding and
cancer such as Hodgkin’s lymphoma [57]. Based on the
same methodology, two studies observed that inbreeding
and ROH resulted in an increased risk of colorectal cancer
[58,59], whereas a third study could not find such an associ-
ation [60]. Similar disconsonant results have been reported
from studies focusing on countries with high close-kin
unions such as the United Arab Emirates and Qatar, with up
to 54% consanguinity prevalence [52,53]. The two
studies showed that reduced genetic diversity and
inbreeding was associated with a reduced risk of breast,
skin, thyroid and female genital cancers, but an increased
risk of developing leukaemia, lymphoma, colorectal and pros-
tate cancer [61,62]. The incongruous results observed in some
human studies suggest that the effect of genetic diversity and
inbreeding on cancer development may be tumour specific.4. Genetic diversity, inbreeding and cancer in
domestic animals
Strong artificial selection and small founder population size
during domestication of animals have had the unintentional
effect of diminishing genetic diversity, and resulted in the
accumulation of deleterious genetic variants. For example,
despite their exceptional phenotypic diversity, both domestic
dogs and cats have significantly lower genetic diversity com-
pared with their wild conspecifics, and/or their wild
ancestors [63–69]. Apart from additional factors, such as
anthropogenically induced longer lifespan and altered
environment (e.g. diet and exposure to tobacco smoke), the
loss of genetic diversity has been linked to the observed
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[70–73]. Data originating from the histopathology analyses
of more than 30 000 malignant neoplastic cases of cats and
dogs revelead skin being the most frequently affected tissue
in both species, and purebred dogs being more prone to
develop neoplasms in general [72]. The latter finding has
been further supported by a survey from Italy that showed
an almost twofold higher incidence rate of malignant
tumours in both purebred cats and dogs compared with
mixed breeds [73]. These results are not surpising since selec-
tive breeding of dogs led to some breeds descending from a
few founders with documented increased risk for certain dis-
eases, such as osteosarcoma, histiocytic sarcoma and
squamous cell carcinoma [74]. Recent genomic comparison
of healthy golden retrievers with golden retrievers suffering
from mast cell tumours (MCT) identified potential causative
genetic variations in multiple hyaluronidase genes [75],
while an other study demonstarted significant association
between germline mutations of BRAC1/2 genes and
mammary cancer in English springer spaniels [27].
Lymphoma, the most common haematopoietic cancer of
cats, can be initiated by retroviral infections—such as feline
leukaemia virus (FeLV) and feline immunodeficiency virus
(FIV)—or by additional factors, such as chronic cigarette
smoke exposure and chronic inflammation (revewied in
[76]). In addition, similar to dogs, breed-specific predisposi-
tion for lymphoma with a recessive pattern of inheritance
has been observed in Siamese cats and Oriental shorthair
cats (revewied in [76]). Selecting phenotypic traits and
specific functions may have inadvertently contributed to the
increased suceptibility of our feline and canine companions
to both infectious and heritable oncogenesis.5. Genetic diversity, inbreeding and cancer in
wildlife
Despite neoplasia being recorded in most metazoans [77], and
being common in domesticated animals, it has generally been
assumed to be rare in the wild. In our view this is most likely
to be due to the fact that cancer prevalence in wildlife is extre-
mely difficult to identify and reports are highly scattered in
the scientific literature, and hence challenging to access [18].
In some fish populations cancer prevalence can actually reach
100%, being caused by contagious agents, pollution, inbreeding
or the combination of all these factors [18,78]. Moreover, the
high cancer prevalence (26%) recorded in some populations of
California sea lions (Zalophus californianus) has been suggested
to be caused by a herpesvirus and/or persistent organic pollu-
tants, but a high prevalence of urogenital carcinoma has been
linked to loss of genetic diversity at a single locus, the hepara-
nase 2 gene (HPSE2) [79]. Additionally, two recent studies
have observed a link between low genetic diversity and high
cancer prevalence (greater than 50%) in Santa Catalina Island
foxes (Urocyon littoralis catalinae) [80,81] and the South African
Cape mountain zebra (Equus zebra zebra) [82–84].6. Genetic diversity, inbreeding and cancer
development
Cancer being a multifaceted disease, loss of genetic diversity
and inbreeding can impact cancer emergence both directlyand indirectly (electronic supplementary material, table S2).
Reduction of population size, cultural traditions promoting
consanguineous marriages and natural selection purging
favouring certain haplotypes contribute to an increased like-
lihood of a reduction in genetic diversity, which may result in
a higher frequency of long stretches of ROH regions [85,86].
ROH harbour disproportionately more deleterious homozy-
gotes than other parts of the genome [85], and the presence
of identical pathogenic variants of both alleles have been
shown to result in recessive disorders [51,87]. Reduced
genetic diversity magnifies the impact of deleterious homo-
zygous mutations [85], and genomic studies suggest that
homozygosity of some germline low-penetrance cancer
genes act as significant contributing factors to the develop-
ment of human oesophageal [88], oral [89], lung [90,91],
bladder [92], acute lymphocytic leukaemia [93] and breast
cancers [61,94,95].
Apart from the direct role of cancer increasing homozy-
gous genomic regions, a general reduction in genetic
diversity can also contribute to the development of tumours
via infectious agents such as viruses (e.g. [34,38,96]). Loss of
genetic diversity at important immune gene loci such as the
major histocompatibility complex (MHC), Toll-like recep-
tors (TLRs) and type I and II interferons [12,97], can
increase the risk of pathogen infections that either directly
or indirectly initiate malignant transformations. For
example, genetic variants of interferon genes have not
only been associated with pathogen resistance (including
carcinogenic helminth infections) [98–102], but have also
been shown to influence melanoma progression and survi-
val in humans [103]. Furthermore, hepatitis C virus
(HCV), one of the most common chronic blood-borne infec-
tions, results in chronic hepatitis in approximately 80% of
infected patients, and leads to death in up to 5% of these
patients from hepatocellular carcinoma (HCC) or liver
cancer [104]. A complex interplay between host genetics,
immunology and viral factors has been proposed to deter-
mine the outcome of HCV infection [104–107]. Ethnic
background, immune gene polymorphism as well as the
presence of specific alleles (e.g. interleukin 28B, inhibitory
natural killer cell receptors and MHC classes I and II, and
variants of interferon (IFN)L3-IFNL4, etc.) have been ident-
ified as key elements of HCV clearance, and consequent
disease progression [104–107].
Helicobacter pylori infections, an underlying factor of
gastric cancer, provide an excellent example of how the
host genotype may indirectly contribute to initiation of
malignant transformations. Helicobacter pylori affects at least
50% of humans worldwide, and hence owns the uncoveted
title of being ‘the most common single chronic bacterial infec-
tion in the world’ [108]. The bacteria and their human host
have a long evolutionary history; anatomically modern
humans were already infected by H. pylori prior to leaving
Africa and the close association remains ever since [109].
The majority of infected individuals develop no significant
disease, but clinical outcomes range from asymptomatic gas-
tritis to peptic ulcer disease and gastric cancer [108]. Risk of
infection, prevalence and disease outcomes have been
linked to ethnicity, socioeconomic status, and behavioural
and genetic variables [110]. One of the most challenging
scientific conundrums is to explain individual predisposition
to the disease—why some individuals develop serious seque-
lae of H. pylori infections, while others don’t [108].
rspb.royalsocietypublishing.org
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terial and host genetic factors, and a twin study showed
that both host genetic and environmental factors (‘rearing
environment’) influence the acquisition of H. pylori infection
[111]. Importantly, host proinflammatory genetic makeup
appears to have a major contribution to the pathogenesis of
gastric cancer. Individuals with proinflammatory genotypes
(IL-1B-511*T carriers/IL-1RN*2 homozygotes) have an
increased risk for gastric carcinoma. The carriers of the
specific genotypes generate heightened inflammatory
response to H. pylori infection, which ultimately creates a
chronically inflamed environment with elevated oxidative/
genotoxic stress (due to hypochlorhydria) and eventually
initiates a proneoplastic drive [108,112]. Apart from the gen-
etic factors, socioeconomic variables and industrialized
environments have also been associated with chronic gastri-
tis, peptic ulcer disease and gastric cancers [110]. While
gastric carcinoma is more common in the developing
world, the less severe chronic gastritis and peptic ulcers are
more frequently reported from the developed world [110].
These might be due to reporting, or due to disease presen-
tation being related to the age of infection (i.e. early
childhood infections are postulated to develop over time
into pre-malignant changes and eventually gastric carcinoma,
in contrast to infection during adulthood, which is more
likely to result in ulcer disease [110]). Regional and ethnic
variations of H. pylori aetiology have been observed and dis-
cussed since the links between infection, peptic ulcer disease
and gastric adenocarcinomas [113] have been established
(reviewed in [114]). More recent studies identify environ-
mental factors such as food preservation and diet as
primary determinants of disease outcomes [114]. Helicobacter
pylori infection is clearly a complex disease with a long
coevolutionary history between the host and its parasite,
which requires further studies to determine prevention and
treatment strategies [115].
Reduced genetic diversity may also increase suscepti-
bility of endangered wildlife species to pathogens and their
associated cancers both in captive populations as well as in
the wild. For example, the low genetic diversity of the Aus-
tralian western barred bandicoots (Perameles bougainville)
(WBB) [116] has been proposed to be one of the potential
underlying factors of high prevalence of papillomatosis and
carcinomatosis syndrome (up to 61.4% prevalence in captive
breeding facilities) [117]. By using microsatellite markers,
Smith & Hughes [116] estimated the WBB’s genetic diversity
to be one of the lowest ever recorded in marsupials, and
Woolford et al. [117] proposed that the reduced genetic
diversity may contribute to the species’s susceptibility to
(oncogenic) viruses.
Low genetic diversity at microsatellite loci and lack of
variations in mitochondrial DNA (mtDNA) indicate that
another endangered species, the snow leopard (Uncia
uncia), has undergone a genetic bottleneck approximately
8000 years ago [118]. Although no information on cancer
prevalence is available from wild snow leopards, a survey
by Joslin et al. [119] revealed that 9% of mortalities in 66 insti-
tutions involved with the Snow Leopard Species Survival
Plan (SSP) was due to squamous cell carcinomas (SCC).
Papillomas with viral aetiology have been identified as pre-
cursors to SCC in felines, including cats and snow leopards
[119]. Low genetic diversity of snow leopards may therefore
potentially be a contributing factor to viral infections andultimately the development of SCCs observed in captivity
[119]. Comparative genetics of sarcoid tumour-affected and
non-affected mountain zebra (Equus zebra) populations
revealed that tumour-affected populations had higher homo-
zygosity and relatedness, and lower gene diversity and
polymorphism, at 16 microsatellite loci compared with
healthy populations (although the levels were not significant
(p ¼ 0.05) [83]). A study of 371 stranded California sea lions
(Zalophus californianus) also found a clear association between
carcinoma incidence and close genetic relatedness when ana-
lysing 11 microsatellite markers [120]. Furthermore, as
discussed above, inbreeding depression (estimated based on
microsatellite multilocus heterozygosity) and homozygosity
of the heparanase 2 gene (HPSE2) locus have been identified
as predictors of urogenital carcinoma in sea lions [121].
Finally, the high cancer prevalence observed in the highly
inbred Santa Catalina Island foxes [80,81] also strongly
suggest an association between loss of genetic diversity and
cancer development in wildlife (electronic supplementary
material, table S2).7. Conclusion
As mentioned above, maintenance of genetic diversity is fun-
damental for adaptive capacities and provides organisms
with an ability to successfully respond to challenges caused
by parasites/pathogens [122], habitat fragmentation [3,123]
and global climate change [124,125]. In contrast to parasites
and pathogens cancer, has so far been largely overlooked as
a significant determinant of wildlife fitness. The present
review, however, suggests that low genetic diversity and
inbreeding may elevate cancer development in wildlife,
further imperilling the long-term survival of the numerous
species presently suffering from low genetic diversity. Our
review hence demonstrates the need to consider the effects
of cancer in conservation biology.
The results originating from human studies indicate that
the effects of genetic diversity and inbreeding on the develop-
ment of a complex disease such as cancer may be tumour
specific. Importantly, by reducing immune function, and
thereby increasing the vulnerability to cancer causing para-
site/pathogen infections, overall loss of genetic diversity
and inbreeding may therefore constitute a significant under-
pinning of cancer development in humans as well as in
other organisms [126,127]. Finally, the link between low gen-
etic diversity/inbreeding and cancer may be just as arduous
as the disease itself, and further studies, including genome-
wide association studies on both domestic and wild
animals, population genetic and genomic analyses of species
affected by high prevalence of cancer, and epidemiological
studies likening infectious diseases to cancer prevalence, are
therefore urgently needed to decipher the underpinnings of
such associations.
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